Skye Bioscience (SKYE) Interest Coverage Ratio (2013 - 2026)

Skye Bioscience (SKYE) has reported Interest Coverage Ratio for 11 consecutive years, with 3352.93 the latest figure, recorded in Q2 2026.

• On a quarterly basis, Interest Coverage Ratio changed N/A year-over-year to 3352.93 in Q2 2026; TTM through Jun 2026 was 9439.02, a 2917.5% decrease from a year earlier, with the FY2024 full-year figure at 40.29, down 5.13% from the prior year.
• Interest Coverage Ratio was 3352.93 for Q2 2026 at Skye Bioscience, up from 5763.7 in the prior quarter.
• Over five years, Interest Coverage Ratio peaked at 227.35 in Q4 2024 and troughed at 8098.87 in Q1 2025.
• A 5-year average of 1165.45 and a median of 15.68 in 2022 frame the typical range for Interest Coverage Ratio.
• Across the five-year window, Interest Coverage Ratio jumped 2493.22% in 2024 and tumbled 57418.61% in 2025, its largest moves.
• Over 5 years, Interest Coverage Ratio stood at 187.27 in 2022, then surged by 94.93% to 9.5 in 2023, then jumped by 2493.22% to 227.35 in 2024, then plunged by 3662.22% to 8098.87 in 2025, then soared by 58.6% to 3352.93 in 2026.
• The last three Interest Coverage Ratio figures came in at 3352.93 (Q2 2026), 5763.7 (Q1 2026), and 8098.87 (Q1 2025), per Business Quant data.